Ancor Capital buys STATinMED Research

Ancor Capital Partners said Sept. 10 that it acquired STATinMED Research. Financial terms weren’t announced. StatinMed, of Ann Arbor, Michigan, is a medical technology company in the health economics and outcomes research – HEOR – industry.

10 September 2018•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles